You are here

GED-0301

5 Drugs That Could Make Celgene the Best Biotech Stock of the Next Decade

Motley Fool

Wed, 09/27/17 - 11:22 am

Celgene Skips the Placebo, Fails Drug Development 101

TheStreet.com

Wed, 10/19/16 - 10:51 am

drug development

clinical trials

Crohn's Disease

Celgene Crohn's Pill Data Unspectacular but Perhaps Good Enough

TheStreet.com

Mon, 10/17/16 - 11:39 am

Crohn's Disease

Celgene Is Building an Autoimmune Empire -- and No One Is Talking About It

Motley Fool

Sun, 10/2/16 - 10:19 am

autoimmune disease

Celgene’s update on its big Crohn’s drug? Trust us, we’re doing fine

Endpoints

Mon, 09/12/16 - 09:27 am

Crohn's Disease

Next Up for Celgene's Crohn's Pill: A Snapshot Inside Patients' Colons

TheStreet.com

Fri, 07/15/16 - 10:41 am

Crohn's Disease

Does Celgene Have Another Blockbuster on the Way?

Investopedia

Thu, 03/26/15 - 09:45 pm

autoimmune disease

Crohn's Disease

First Detailed Look at Celgene Crohn's Disease Pill Impresses

TheStreet.com

Mon, 10/20/14 - 10:55 am

Crohn's Disease

Was Celgene's Crohn's Disease Drug Worth The Price?

Investors.com

Thu, 10/16/14 - 07:48 am

Crohn's Disease

Celgene enters deal potentially worth over $2.5 billion for Nogra Pharma's Crohn's disease drug

First Word Pharma

Thu, 04/24/14 - 11:36 am

Crohn's Disease